Data tracking shows that research coordinators have been more productive working from home, keeping the clinical trial center operating smoothly even during a global pandemic.
Our CEO and President has teamed with leaders from Mayo Clinic to advocate for a national coalition to coordinate hypothesis-driven clinical trials to treat and prevent COVID-19.
Too few cardiovascular clinical trials adjust for multiplicity to avoid possible statistical flaws, a recent study finds. Two study authors outline steps to fix this and explain why trust in clinical research may be at stake.
We were recruiting patients for 75+ cardiovascular clinical trials when COVID-19 struck. Here’s how we’ve worked to keep as many of them on track as possible.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Pregnant women have largely been left out of clinical trials related to COVID-19, increasing the risk to them, as well as their children and families. In this article, Ruth Farrell, MD, MA, explains the reasoning behind a new, city-wide, multi-institution study investigating the impact of COVID-19 on pregnant women and their babies.
Cleveland Clinic is involved in a range of multicenter and single-center trials of therapies and preventive efforts to combat the virus. Here’s a sampling, along with details on some broader COVID-19 research initiatives.
A review of recent major cardiovascular medicine studies reveals that only 1 in 10 first authors, senior authors and trial leadership committee members are women.
We profile four ongoing Cleveland Clinic-led clinical studies that are evaluating mechanistically diverse strategies to extend survival in patients with this formidable malignancy.
A new, multicenter trial has begun enrolling patients to evaluate the role of specific behavioral interventions to prevent the development, progression and recurrence of urinary stone disease in adults and children. This first-of-its kind, randomized clinical trial will extend over a two-year period.
For a full listing of all open and accruing studies, please visit the Head & Neck cancer section of Cleveland Clinic’s Cancer Clinical Trials Database.